BDR-662
N/A
Report date: 2023/10/27 17:49:44
NME
Base Information
Drug NameBDR-662
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMDimune Inc
China Registration ClassN/A
Develop Information
Active CompaniesMDimune IncAustralian National University
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A